跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OVALEAP 450IU/0.75mL follitropin alfa (rch) solution for injection, cartridge - TGA Drug Approval Details
Approvals
/
TGA
/
OVALEAP 450IU/0.75mL follitropin alfa (rch) solution for injection, cartridge
Approved
STANDARD
OVALEAP 450IU/0.75mL follitropin alfa (rch) solution for injection, cartridge
Theramex Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
c4b959849949fd37
Company
Theramex Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
c4b959849949fd37
Product Name
OVALEAP 450IU/0.75mL follitropin alfa (rch) solution for injection, cartridge
Artg Id
328120
Artg Name
OVALEAP 450IU/0.75mL follitropin alfa (rch) solution for injection, cartridge
Sponsor
Theramex Australia Pty Ltd
Company Detail Path
/organization/theramex-australia-pty-ltd
Artg Date
2021-03-10
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/74877aad94ff5ae43f77697cb254a7bf.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/630b034d54f9427451d63ad55bbf166a.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
c4b959849949fd37
Type
Standard
Back to TGA Approvals